Tokyo, Japan

Tomihiko Tanino

This inventor holds 1 USPTO granted patent. Top assignee: R-Tech Ueno, Ltd.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomihiko Tanino. Retrieved from https://idiyas.com/inventor/tomihiko-tanino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tomihiko Tanino

Introduction: Tomihiko Tanino is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medical treatments, particularly in addressing optic nerve disorders. His innovative approach has the potential to improve visual acuity for those in need.

Latest Patents: Tanino holds a patent for the treatment of optic nerve disorder using prostanoic acid compounds. This invention provides a method for treating optic nerve disorders by administering a prostanoic acid compound in an effective amount. The goal of this treatment is to recover visual acuity in subjects who require such intervention. He has 1 patent to his name.

Career Highlights: Tanino is associated with R-Tech Ueno, Ltd., a company that focuses on developing advanced medical treatments. His work at the company has allowed him to explore innovative solutions for complex medical issues.

Collaborations: Throughout his career, Tanino has collaborated with esteemed colleagues such as Yoshihisa Oguchi and Yukihiko Mashima. These partnerships have contributed to the advancement of his research and inventions.

Conclusion: Tomihiko Tanino's contributions to the field of medical innovation, particularly in treating optic nerve disorders, highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments that can enhance the quality of life for many individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…